Transdermal delivery of drugs for urologic applications: Basic principles and applications-Reference-Cited by-同舟云学术

Transdermal delivery of drugs for urologic applications: Basic principles and applications

Published:2006-04 Issue:4 Volume:67 Page:657-664
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Nitti Victor W.,Sanders Steven,Staskin David R.,Dmochowski Roger R.,Sand Peter K.,MacDiarmid Scott,Maibach Howard I.

Publisher

Elsevier BV

Subject

Urology

Reference61 articles.

1. Monitoring serum concentrations for once-daily netilmicin dosing regimens;Blaser;J Antimicrob Chemother,1994

2. Effect of controlled-release delivery on the pharmacokinetics of oxybutynin at different dosages;Preik;BJU Int,2004

3. the Ditropan XL Study Group;Versi;Obstet Gynecol,2000

4. Lee TW, and Robinson JR: Controlled-release drug-delivery systems, in University of the Sciences in Philadelphia (USIP) (Ed): Remington: The Science and Practice of Pharmacy. Baltimore, Lippincott Williams & Wilkins, 2000, pp 903–929.

5. Solvent effects in permeation assessed in vivo by skin surface biopsy;Rosado;BMC Dermatol,2003

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug in adhesive transdermal patch containing antibiotic-loaded solid lipid nanoparticles;Journal of Bioscience and Bioengineering;2022-11

2. Current pharmacotherapy of overactive bladder;International braz j urol;2021-12

3. Individualizing Drug Therapy;Contemporary Pharmacotherapy of Overactive Bladder;2018-09-26

4. Investigation of molecular mobility of pressure-sensitive-adhesive in oxybutynin patch in vitro and in vivo : Effect of sorbitan monooleate on drug release and patch mechanical property;European Journal of Pharmaceutical Sciences;2018-09

5. Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation;Acta Pharmaceutica;2017-08-30